NOZZOLILLO, AGOSTINO
 Distribuzione geografica
Continente #
EU - Europa 208
NA - Nord America 137
AS - Asia 100
SA - Sud America 22
AF - Africa 10
Totale 477
Nazione #
US - Stati Uniti d'America 134
RU - Federazione Russa 109
SG - Singapore 60
IT - Italia 33
DE - Germania 24
BR - Brasile 20
HK - Hong Kong 20
GB - Regno Unito 11
NL - Olanda 8
CI - Costa d'Avorio 7
FI - Finlandia 7
FR - Francia 6
IN - India 6
VN - Vietnam 6
AT - Austria 4
CN - Cina 4
CA - Canada 3
IQ - Iraq 2
UA - Ucraina 2
AR - Argentina 1
BD - Bangladesh 1
BE - Belgio 1
IE - Irlanda 1
KE - Kenya 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
SE - Svezia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 477
Città #
Moscow 36
Singapore 36
Santa Clara 23
Hong Kong 20
Ashburn 13
Chandler 10
Munich 9
Frankfurt am Main 7
Boston 5
Lawrence 5
Millbury 5
Naples 5
Amsterdam 4
Des Moines 4
Dong Ket 4
Helsinki 3
London 3
Milan 3
Afragola 2
Basildon 2
Belo Horizonte 2
Dallas 2
Falkenstein 2
Grottaferrata 2
Hefei 2
Lappeenranta 2
Montreal 2
Redhill 2
Rome 2
The Dalles 2
Turku 2
Vienna 2
Wilmington 2
Acaraú 1
Alegre 1
Alto Paraíso de Goiás 1
Beachwood 1
Beijing 1
Belén de Escobar 1
Berrechid 1
Betim 1
Brussels 1
Campo San Martino 1
Cape Town 1
Caruaru 1
Cataguases 1
Catania 1
Catende 1
Cerrione 1
Chennai 1
Chicago 1
Derby 1
Dorset 1
Dublin 1
Düsseldorf 1
Erbil 1
Fairfield 1
Fremont 1
Goiânia 1
Ho Chi Minh City 1
Indaiatuba 1
Juiz de Fora 1
Junction City 1
Kolkata 1
Kursk 1
Lauterbourg 1
Linhares 1
Los Angeles 1
Miranda 1
Morrinhos 1
Nairobi 1
Napoli 1
Nuremberg 1
Ottawa 1
Palermo 1
Paris 1
Perugia 1
Phoenix 1
Portsmouth 1
Pune 1
Quận Phú Nhuận 1
Raipur 1
Rio Grande 1
Rio de Janeiro 1
San Sebastiano Al Vesuvio 1
Santa Maria 1
Seoul 1
Stockholm 1
São Paulo 1
Torre del Greco 1
Tupi Paulista 1
Vitória de Santo Antão 1
Zakho 1
Totale 285
Nome #
Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience 71
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 71
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis 60
Signs and symptoms of COVID-19 in patients with multiple sclerosis 57
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study) 49
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 46
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 46
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials 44
Sexual dysfunction in people with multiple sclerosis: The role of disease severity, illness perception, and depression 35
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 22
Totale 501
Categoria #
all - tutte 2.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 3 1 0 0 0 0 0 0 4
2021/202235 1 0 0 3 0 2 0 1 1 7 7 13
2022/202345 5 2 1 0 3 7 1 4 13 6 3 0
2023/202450 1 9 1 2 2 6 6 7 1 2 6 7
2024/2025340 10 15 1 3 13 24 36 31 28 33 113 33
2025/202617 17 0 0 0 0 0 0 0 0 0 0 0
Totale 501